Healthcare Dive reports that US regulators have extended their authority to revoke Medicare certification from providers, including parent companies, when owners break federal rules. The measure increases regulatory scrutiny of ownership conduct in the healthcare sector.

This change means healthcare providers and investors face greater risk if owners or parent organisations breach compliance standards. Boards and executives should consider reviewing ownership structures and compliance frameworks to reduce exposure to enforcement actions.

Healthcare Dive reports that US regulators have finalised a cut to Medicare payments for doctors in 2027, along with other policy changes aimed at reducing duplicative reimbursement. Providers criticised the move, arguing it could further destabilise the sector.

This decision matters for senior executives in healthcare and pharma, as changes to provider reimbursement can affect network stability and patient access. Leaders should monitor how these adjustments may influence contract negotiations and care delivery models.

Healthcare Dive reports that Mayo Clinic Platform has launched an AI chatbot, allowing clinicians to query its medical knowledge base for support with diagnosis and care decisions across more than 35 specialties.

This development may affect how healthcare providers use AI to support clinical decision-making. Leaders in the sector should consider how such tools might integrate with existing systems and influence care quality and operational efficiency.

Medicare is paying almost $1,000 more per stay at hospices acquired by private equity firms, according to researchers cited by Healthcare Dive. The study suggests that these firms may be increasing inappropriate admissions to drive up reimbursement.

This finding matters for healthcare executives and insurers, as it signals possible regulatory and financial risks linked to private equity involvement in care delivery. Leaders should consider how ownership structures may affect both compliance and cost control.

MultiCare and Samaritan, two nonprofit health systems, have completed their merger after receiving state regulatory approval, according to Healthcare Dive. MultiCare, based in Tacoma, Washington, will invest $700 million over the next decade to upgrade Samaritan’s facilities and technology.

This move signals a significant capital commitment to infrastructure and digital systems in the merged organisation. Senior healthcare executives should consider the implications for regional competition, care standards and future regulatory reviews of similar deals.

KFF, a health policy think tank, said Medicare Part D premiums are set to rise by 50% on average next year. The group advised seniors to compare prescription drug plans carefully during open enrolment, citing sharp premium increases and wide cost differences between plans.

This increase puts pressure on health insurers and may prompt policy changes or member outreach. Executives in healthcare and insurance should expect more scrutiny from both regulators and consumers as costs rise.

The AMA, according to Healthcare Dive, has issued an issue brief stating that physicians, AI developers and healthcare organisations all have distinct responsibilities for clinical AI. The brief argues that patient protection depends on accountability across all parties involved in the AI ecosystem.

This move signals a shift in how liability is distributed in healthcare AI. It matters for leaders in healthcare and biotech, as risk and compliance strategies may need to be updated to reflect shared responsibilities for AI-driven decisions in patient care.

According to Healthcare Dive, CVS has filed a lawsuit to stop a $2 billion loss tied to a drop in its Medicare Advantage star ratings. The report notes CVS is at least the fifth insurer to challenge the ratings in court, but its case claims the largest financial impact so far.

Insurers are contesting the rating system, making similar legal arguments about its fairness and calculation. For healthcare executives and insurers, the outcome could affect future ratings, reimbursement, and regulatory risk. The legal strategy and regulatory response may shape how other firms approach ratings disputes.

Healthcare Dive reports that Centene is forecasting its Medicare business will break even a year ahead of schedule, following a strong third quarter. The company has reduced its workforce by 6,000, which led to immediate severance expenses but is expected to improve margins by 2027.

This development signals ongoing cost control efforts among major US insurers. For healthcare executives, the early break-even and job cuts indicate continued pressure to balance profitability with operational efficiency. Further restructuring or shifts in workforce strategy could affect industry benchmarks.

Centene has filed a lawsuit against the US Centres for Medicare & Medicaid Services (CMS) over its 2027 Medicare Advantage star ratings, according to Healthcare Dive. The insurer joins other companies seeking to have their quality scores recalculated, aiming to secure hundreds of millions of dollars in additional payments.

This dispute matters for health insurers and financial leaders, as star ratings directly influence bonus payments and regulatory standing. The legal action signals ongoing tension between insurers and the regulator over quality metrics and funding.